Author:
Sadri Iman,Chakraborty Anindyo,Nguyen David-Dan,Arezki Adel,Oumedjbeur Kussil,Bhojani Naeem,Elterman Dean,Chughtai Bilal,Gilling Peter,Barber Neil,Badlani Gopal,Desai Mihir,Doumanian Leo,Te Alexis E.,Roehrborn Claus,Zorn Kevin C.
Reference28 articles.
1. Management of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms; 2021.
2. WATER II (80–150 mL) procedural outcomes;Desai;BJU Int,2019
3. WATER: a double-blind, randomized, controlled trial of Aquablation® vs transurethral resection of the prostate in benign prostatic hyperplasia;Gilling;J Urol,2018
4. Aquablation for benign prostatic hyperplasia in large prostates (80-150 cc): 2-year results;Desai;Can J Urol,2020
5. Five-year outcomes for Aquablation therapy compared to TURP: results from a double-blind, randomized trial in men with LUTS due to BPH;Gilling;Can J Urol,2022